Will Lautzenheiser, 42, who lost all four limbs to a vicious strep infection, has prosthetic legs and transplanted arms. He went through a rigorous 18-month course of occupational therapy to learn how to use his new limbs for daily activities.
Plastic and reconstructive surgeons Lisa Cassileth and Kelly Killeen say women who have undergone mastectomy have a right to expect high-quality, aesthetically pleasing reconstruction. They work with breast surgeons who know how to do nipple-sparing mastectomy and have low complication rates, and they get patients' partners involved in the reconstruction process.
The Stratafix Spiral PDS Plus and Stratafix Spiral Monocryl Plus Knotless Tissue Control devices have been launched by Johnson & Johnson subsidiary Ethicon. The sutures offer greater strength and security and higher consistency in performance compared with traditional suturing and allow for easier tension management and control of tissue approximation, the company said.
The CMS announced that the one-year grace period for medical claims using the ICD-10 code set will end on Oct. 1, and health care organizations will be required to use the correct degree of specificity when coding claims. Unspecified codes may still be used when needed, the agency said.
The UK's Care Quality Commission will issue online quality ratings for as many as 100 cosmetic surgery clinics. Douglas McGeorge, former president of the British Association of Aesthetic Plastic Surgeons, welcomed the news but cautioned consumers to be aware that only clinics and not individual surgeons will be rated.
An experimental hand-held device called SkinGun, which takes about 90 minutes to spray stem cells on burn injuries to provide skin regeneration within days, has been developed by New York-based medtech startup RenovaCare. The company will initially concentrate on US commercialization of the device, which may eventually be developed and evaluated for treating other skin conditions and injuries after securing FDA clearance for burn treatment, said RenovaCare CEO Thomas Bold.